TY - RPRT
T1 - Scientific Opinion on the substantiation of health claims related to eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), docosapentaenoic acid (DPA) and maintenance of normal cardiac function (ID 504, 506, 516, 527, 538, 703, 1128, 1317, 1324, 1325), maintenance of normal blood glucose concentrations (ID 566), maintenance of normal blood pressure (ID 506, 516, 703, 1317, 1324), maintenance of normal blood HDL-cholesterol concentrations (ID 506), maintenance of normal (fasting) blood concentrations of triglycerides (ID 506, 527, 538, 1317, 1324, 1325), maintenance of normal blood LDL-cholesterol concentrations (ID 527, 538, 1317, 1325, 4689), protection of the skin from photo-oxidative (UV-induced) damage (ID 530), improved absorption of EPA and DHA (ID 522, 523)
T2 - contribution to the normal function of the immune system by decreasing the levels of eicosanoids, arachidonic acid-derived mediators and pro-inflammatory cytokines (ID 520, 2914), and “immunomodulating agent” (4690) pursuant to Article 13(1) of Regulation (EC) No 1924/2006
AU - Tetens, Inge
PY - 2010
Y1 - 2010
N2 - EFSA-Q-2008-1291 , EFSA-Q-2008-1293 , EFSA-Q-2008-1303 , EFSA-Q-2008-1307 , EFSA-Q-2008-1309 , EFSA-Q-2008-1310 , EFSA-Q-2008-1314 , EFSA-Q-2008-1317 , EFSA-Q-2008-1325 , EFSA-Q-2008-1353 , EFSA-Q-2008-1490 , EFSA-Q-2008-1867 , EFSA-Q-2008-2054 , EFSA-Q-2008-2061 , EFSA-Q-2008-2062 , EFSA-Q-2008-3647 , EFSA-Q-2010-00642 , EFSA-Q-2010-00643
AB - EFSA-Q-2008-1291 , EFSA-Q-2008-1293 , EFSA-Q-2008-1303 , EFSA-Q-2008-1307 , EFSA-Q-2008-1309 , EFSA-Q-2008-1310 , EFSA-Q-2008-1314 , EFSA-Q-2008-1317 , EFSA-Q-2008-1325 , EFSA-Q-2008-1353 , EFSA-Q-2008-1490 , EFSA-Q-2008-1867 , EFSA-Q-2008-2054 , EFSA-Q-2008-2061 , EFSA-Q-2008-2062 , EFSA-Q-2008-3647 , EFSA-Q-2010-00642 , EFSA-Q-2010-00643
KW - EPA
KW - blood pressure
KW - DPA
KW - LDL-cholesterol
KW - HDL-cholesterol
KW - health claims
KW - blood lipids
KW - cardiovascular
KW - triglycerides
KW - DHA
M3 - Report
BT - Scientific Opinion on the substantiation of health claims related to eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), docosapentaenoic acid (DPA) and maintenance of normal cardiac function (ID 504, 506, 516, 527, 538, 703, 1128, 1317, 1324, 1325), maintenance of normal blood glucose concentrations (ID 566), maintenance of normal blood pressure (ID 506, 516, 703, 1317, 1324), maintenance of normal blood HDL-cholesterol concentrations (ID 506), maintenance of normal (fasting) blood concentrations of triglycerides (ID 506, 527, 538, 1317, 1324, 1325), maintenance of normal blood LDL-cholesterol concentrations (ID 527, 538, 1317, 1325, 4689), protection of the skin from photo-oxidative (UV-induced) damage (ID 530), improved absorption of EPA and DHA (ID 522, 523)
PB - European Food Safety Authority
ER -